If you are interested in participating in a Duke Vaccine and Trials Unit study, please contact us to receive notices about current and future research studies.
Email: dvtustudies@duke.edu | Telephone: 919-971-5649
Active Clinical Trials
Dr. Walter is leading a study designed to obtain blood from Duke employees who are recovering from SARS-CoV-2 infection for the purposes of neutralizing antibody assay validation. No NCT number.
Dr. Smith is leading a study to assess the safety, tolerability, and immunogenicity of a multivalent pneumococcal conjugate vaccine in infants. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT007629440.
Dr. Walter is leading a study to learn about a Clostridioides difficile vaccine in people 65 years of age and older. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT07282665.
Dr. Woods is leading a controlled human infection model study to determine the optimal dose of a pH1N1 influenza virus. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT07110532.
Dr. Smith is leading a study to assess the safety of RSV prevenetive monoclonal antibody when administered with routine childhood immunisation. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT007158814.